9-127666205-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001032221.6(STXBP1):c.703C>T(p.Arg235*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001032221.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.703C>T | p.Arg235* | stop_gained | Exon 9 of 20 | 1 | NM_003165.6 | ENSP00000362399.3 | ||
STXBP1 | ENST00000373299.5 | c.703C>T | p.Arg235* | stop_gained | Exon 9 of 19 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 4 Pathogenic:4Other:1
- -
- -
Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported as de novoo in similarly affected individuals (ClinVar ID: VCV000207422.7, PMID: 25497044, 20887364). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
The stop gained p.R235* in STXBP1 (NM_003165.4) has been reported previously with infantile spasms (Saitsu et al, 2010; Allen et al, 2013; Boutry-Kryza et al, 2014). It has been submitted to ClinVar as Pathogenic. It is novel (not in any individuals) in 1000 Genomes as well as gnomad. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing in STXBP1. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:3
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 23934111, 20887364, 26817790, 24189369, 25497044, 29186148, 30174244, 27054081, 27905812, 31572294, 32139178, 30488659) -
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg235*) in the STXBP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STXBP1 are known to be pathogenic (PMID: 20887364, 26384463). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with epileptic encephalopathy and/or infantile spasms (PMID: 23934111, 25497044, 29186148). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207422). For these reasons, this variant has been classified as Pathogenic. -
STXBP1-related disorder Pathogenic:1
This nonsense variant found in exon 9 of 20 is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant has been previously reported as a de novo change in patients with epileptic encephalopathy (PMID: 20887364, 23934111, 29186148). Loss-of-function variation in STXBP1 is an established mechanism of disease (PMID: 26384463). The c.703C>T (p.Arg235Ter) variant is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.703C>T (p.Arg235Ter) variant is classified as Pathogenic. -
Infantile epilepsy syndrome Pathogenic:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-04-12 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. This variant was identified in multiple probands enrolled in Simons Searchlight. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at